Fennec Pharmaceuticals (FENC) Enterprise Value Growth (1y) (2011 - 2025)
Fennec Pharmaceuticals (FENC) Enterprise Value Growth (1y) (2011 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Fennec Pharmaceuticals | 346.75 Mn | 309.97 Mn | 12.01 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -38.12% |
| Sep 30, 2025 | 45.57% |
| Jun 30, 2025 | 56.55% |
| Mar 31, 2025 | 55.70% |
| Dec 31, 2024 | -100.72% |
| Sep 30, 2024 | -225.19% |
| Jun 30, 2024 | -187.83% |
| Mar 31, 2024 | -285.74% |
| Dec 31, 2023 | 44.19% |
| Sep 30, 2023 | 58.33% |
| Jun 30, 2023 | -0.29% |
| Mar 31, 2023 | 27.33% |
| Dec 31, 2022 | -12.67% |
| Sep 30, 2022 | -22.26% |
| Jun 30, 2022 | 45.35% |
| Mar 31, 2022 | 31.74% |
| Dec 31, 2021 | 30.46% |
| Sep 30, 2021 | 26.63% |
| Jun 30, 2021 | 29.53% |
| Mar 31, 2021 | -170.18% |